Rejection Acute Renal

Also known as: Acute allograft nephropathy / Renal transplant rejection / Kidney transplant rejection

Drug	Drug Name	Drug Description
DB00098	Antithymocyte immunoglobulin (rabbit)	A purified form of rabbit anti-thymocyte antibodies used for immunosuppression in patients receiving kidney transplants.
DB00074	Basiliximab	A monoclonal anti-C25 antibody (interleukin-2 receptor alpha subunit) used as immunosuppressive therapy in kidney transplant patients.

Drug	Drug Name	Target	Type
DB00098	Antithymocyte immunoglobulin (rabbit)	T-cell surface glycoprotein CD1a	target
DB00098	Antithymocyte immunoglobulin (rabbit)	Major histocompatibility complex class I-related gene protein	target
DB00098	Antithymocyte immunoglobulin (rabbit)	Integrin alpha-L	target
DB00098	Antithymocyte immunoglobulin (rabbit)	T-lymphocyte activation antigen CD86	target
DB00098	Antithymocyte immunoglobulin (rabbit)	Low affinity immunoglobulin gamma Fc region receptor II-b	target
DB00098	Antithymocyte immunoglobulin (rabbit)	T-cell surface glycoprotein CD4	target
DB00098	Antithymocyte immunoglobulin (rabbit)	Integrin beta-1	target
DB00098	Antithymocyte immunoglobulin (rabbit)	Integrin alpha-V	target
DB00098	Antithymocyte immunoglobulin (rabbit)	Integrin beta-3	target
DB00074	Basiliximab	Interleukin-2 receptor subunit alpha	target
DB00074	Basiliximab	Interleukin-2 receptor subunit beta	target

Drug	Drug Name	Phase	Status	Count
DB01024	Mycophenolic acid	Not Available	Unknown Status	1
DB00864	Tacrolimus	Not Available	Unknown Status	1